Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C VanderVen

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Cell Host & Microbe|July 20, 2010
Mycobacterium tuberculosis wears what it eatsDavid G Russell, Brian C VanderVen, Wonsik Lee, et al.
ACS Medicinal Chemistry Letters|December 17, 2025
Design, Synthesis, and Biological Evaluation of Tetrazol-2-yl-acetamides as Novel Antitubercular AgentsBaiyuan Yang, Paridhi Sukheja, Jasmine Webb, et al.
Elife|July 15, 2017
Rv3723/LucA coordinates fatty acid and cholesterol uptake in <i>Mycobacterium tuberculosis</i>Evgeniya V Nazarova, Christine R Montague, Thuy La, et al.
The Journal of Experimental Medicine|April 27, 2016
Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivoYancheng Liu, Shumin Tan, Lu Huang, et al.
The Journal of Biological Chemistry|June 16, 2017
Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activationMaidina Tuohetahuntila, Martijn R Molenaar, Bart Spee, et al.
The Journal of Biological Chemistry|January 15, 2023
MceG stabilizes the Mce1 and Mce4 transporters in Mycobacterium tuberculosisRachael A Fieweger, Kaley M Wilburn, Christine R Montague, et al.
Communications Biology|July 9, 2022
Iron limitation in M. tuberculosis has broad impact on central carbon metabolismMonique E Theriault, Davide Pisu, Kaley M Wilburn, et al.
Antimicrobial Agents and Chemotherapy|January 5, 2023
Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in <i>Mycobacterium tuberculosis</i> by the Novel Drug Candidate GSK2556286Kirstin L Brown, Kaley M Wilburn, Christine R Montague, et al.
Plos Pathogens|February 8, 2022
Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosisKaley M Wilburn, Christine R Montague, Bo Qin, et al.
Elife|February 22, 2023
Cyclic AMP is a critical mediator of intrinsic drug resistance and fatty acid metabolism in <i>M. tuberculosis</i>Andrew I Wong, Tiago Beites, Kyle A Planck, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cell Host & Microbe|July 20, 2010
Mycobacterium tuberculosis wears what it eatsDavid G Russell, Brian C VanderVen, Wonsik Lee, et al.
ACS Medicinal Chemistry Letters|December 17, 2025
Design, Synthesis, and Biological Evaluation of Tetrazol-2-yl-acetamides as Novel Antitubercular AgentsBaiyuan Yang, Paridhi Sukheja, Jasmine Webb, et al.
Elife|July 15, 2017
Rv3723/LucA coordinates fatty acid and cholesterol uptake in <i>Mycobacterium tuberculosis</i>Evgeniya V Nazarova, Christine R Montague, Thuy La, et al.
The Journal of Experimental Medicine|April 27, 2016
Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivoYancheng Liu, Shumin Tan, Lu Huang, et al.
The Journal of Biological Chemistry|June 16, 2017
Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activationMaidina Tuohetahuntila, Martijn R Molenaar, Bart Spee, et al.
The Journal of Biological Chemistry|January 15, 2023
MceG stabilizes the Mce1 and Mce4 transporters in Mycobacterium tuberculosisRachael A Fieweger, Kaley M Wilburn, Christine R Montague, et al.
Communications Biology|July 9, 2022
Iron limitation in M. tuberculosis has broad impact on central carbon metabolismMonique E Theriault, Davide Pisu, Kaley M Wilburn, et al.
Antimicrobial Agents and Chemotherapy|January 5, 2023
Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in <i>Mycobacterium tuberculosis</i> by the Novel Drug Candidate GSK2556286Kirstin L Brown, Kaley M Wilburn, Christine R Montague, et al.
Plos Pathogens|February 8, 2022
Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosisKaley M Wilburn, Christine R Montague, Bo Qin, et al.
Elife|February 22, 2023
Cyclic AMP is a critical mediator of intrinsic drug resistance and fatty acid metabolism in <i>M. tuberculosis</i>Andrew I Wong, Tiago Beites, Kyle A Planck, et al.
Pageof 4